-
-
-
-
-
-
-
Biolase (BIOL) Misses Q3 EPS by 156c
-
-
-
-
-
-
-
BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023
-
-
-
-
-
-
-
BIOLASE, Inc to Report Third Quarter 2022 Results on November 10, 2022
-
-
-
-
-
-
-
Biolase (BIOL) Reports Q4 EPS of ($0.03)
-
-
-
-
-
-
-
BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers
-
-
-
-
-
-
-
Biolase (BIOL) Tops Q2 EPS by 5c
-
-
-
-
-
-
-
BIOLASE Reports Third Quarter 2019 Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

